|
1
|
Scott JC, Woods SP, Matt GE, et al:
Neurocognitive effects of methamphetamine: a critical review and
meta-analysis. Neuropsychol Rev. 17:275–297. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shrem MT and Halkitis PN: Methamphetamine
abuse in the United States: contextual, psychological and
sociological considerations. J Health Psychol. 13:669–679. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carvalho M, Carmo H, Costa VM, et al:
Toxicity of amphetamines: an update. Arch Toxicol. 86:1167–1231.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deng X, Wang Y, Chou J and Cadet JL:
Methamphetamine causes widespread apoptosis in the mouse brain:
evidence from using an improved TUNEL histochemical method. Brain
Res Mol Brain Res. 93:64–69. 2001. View Article : Google Scholar
|
|
5
|
Jayanthi S, Deng X, Noailles PA, Ladenheim
B and Cadet JL: Methamphetamine induces neuronal apoptosis via
cross-talks between endoplasmic reticulum and
mitochondria-dependent death cascades. FASEB J. 18:238–251. 2004.
View Article : Google Scholar
|
|
6
|
Cadet JL, Jayanthi S and Deng X: Speed
kills: cellular and molecular bases of methamphetamine-induced
nerve terminal degeneration and neuronal apoptosis. FASEB J.
17:1775–1788. 2003. View Article : Google Scholar
|
|
7
|
Li Y, Hu Z, Chen B, et al: Taurine
attenuates methamphetamine-induced autophagy and apoptosis in PC12
cells through mTOR signaling pathway. Toxicol Lett. 215:1–7. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Darke S, Kaye S, McKetin R and Duflou J:
Major physical and psychological harms of methamphetamine use. Drug
Alcohol Rev. 27:253–262. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaye S, McKetin R, Duflou J and Darke S:
Methamphetamine and cardiovascular pathology: a review of the
evidence. Addiction. 102:1204–1211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Costa GM, Pizzi C, Bresciani B, et al:
Acute myocardial infarction caused by amphetamines: a case report
and review of the literature. Ital Heart J. 2:478–480.
2001.PubMed/NCBI
|
|
11
|
Waksman J, Taylor RN Jr, Bodor GS, et al:
Acute myocardial infarction associated with amphetamine use. Mayo
Clin Proc. 76:323–326. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sztajnkrycer MD, Hariharan S and Bond GR:
Cardiac irritability and myocardial infarction in a 13-year-old
girl following recreational amphetamine overdose. Pediatr Emerg
Care. 18:E11–E15. 2002.PubMed/NCBI
|
|
13
|
Hung MJ, Kuo LT and Cherng WJ:
Amphetamine-related acute myocardial infarction due to coronary
artery spasm. Int J Clin Pract. 57:62–64. 2003.PubMed/NCBI
|
|
14
|
Brennan K, Shurmur S and Elhendy A:
Coronary artery rupture associated with amphetamine abuse. Cardiol
Rev. 12:282–283. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Watts DJ and McCollester L:
Methamphetamine-induced myocardial infarction with elevated
troponin I. Am J Emerg Med. 24:132–134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hong R, Matsuyama E and Nur K:
Cardiomyopathy associated with the smoking of crystal
methamphetamine. JAMA. 265:1152–1154. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wijetunga M, Seto T, Lindsay J and Schatz
I: Crystal methamphetamine-associated cardiomyopathy: tip of the
iceberg? J Toxicol Clin Toxicol. 41:981–986. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Crean AM and Pohl JE: ‘Ally McBeal heart?’
- drug induced cardiomyopathy in a young woman. Br J Clin
Pharmacol. 58:558–559. 2004.
|
|
19
|
Olivetti G, Abbi R, Quaini F, et al:
Apoptosis in the failing human heart. N Engl J Med. 336:1131–1141.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takemura G and Fujiwara H: Role of
apoptosis in remodeling after myocardial infarction. Pharmacol
Ther. 104:1–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Narula J, Haider N, Virmani R, et al:
Apoptosis in myocytes in end-stage heart failure. N Engl J Med.
335:1182–1189. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Narula J, Kolodgie FD and Virmani R:
Apoptosis and cardiomyopathy. Curr Opin Cardiol. 15:183–188. 2000.
View Article : Google Scholar
|
|
23
|
Nickerson T, Pollak M and Huynh H:
Castration-induced apoptosis in the rat ventral prostate is
associated with increased expression of genes encoding insulin-like
growth factor binding proteins 2,3,4 and 5. Endocrinology.
139:807–810. 1998. View Article : Google Scholar
|
|
24
|
Tonner E, Barber MC, Allan GJ, et al:
Insulin-like growth factor binding protein-5 (IGFBP-5) induces
premature cell death in the mammary glands of transgenic mice.
Development. 129:4547–4557. 2002.PubMed/NCBI
|
|
25
|
Beilharz EJ, Klempt ND, Klempt M, et al:
Differential expression of insulin-like growth factor binding
proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient
hypoxic-ischemic injury. Brain Res Mol Brain Res. 18:209–215. 1993.
View Article : Google Scholar
|
|
26
|
McManus MT and Sharp PA: Gene silencing in
mammals by small interfering RNAs. Nat Rev Genet. 3:737–747. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iwasa M, Maeno Y, Inoue H, Koyama H and
Matoba R: Induction of apoptotic cell death in rat thymus and
spleen after a bolus injection of methamphetamine. Int J Legal Med.
109:23–28. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Davidson C, Gow AJ, Lee TH and Ellinwood
EH: Methamphetamine neurotoxicity: necrotic and apoptotic
mechanisms and relevance to human abuse and treatment. Brain Res
Brain Res Rev. 36:1–22. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smith HJ, Roche AH, Jausch MF and Herdson
PB: Cardiomyopathy associated with amphetamine administration. Am
Heart J. 91:792–797. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kalant H and Kalant OJ: Death in
amphetamine users: causes and rates. Can Med Assoc J. 112:299–304.
1975.PubMed/NCBI
|
|
31
|
Li X, Wang H, Qiu P and Luo H: Proteomic
profiling of proteins associated with methamphetamine-induced
neurotoxicity in different regions of rat brain. Neurochem Int.
52:256–264. 2008. View Article : Google Scholar
|
|
32
|
Butt AJ, Dickson KA, Jambazov S and Baxter
RC: Enhancement of tumor necrosis factor-alpha-induced growth
inhibition by insulin-like growth factor-binding protein-5
(IGFBP-5), but not IGFBP-3 in human breast cancer cells.
Endocrinology. 146:3113–3122. 2005. View Article : Google Scholar
|
|
33
|
Su Y, Wagner ER, Luo Q, et al:
Insulin-like growth factor binding protein 5 suppresses tumor
growth and metastasis of human osteosarcoma. Oncogene.
30:3907–3917. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanno B, Vitali R, De Arcangelis D, et al:
Bim-dependent apoptosis follows IGFBP-5 down-regulation in
neuroblastoma cells. Biochem Biophys Res Commun. 351:547–552. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cobb LJ, Salih DA, Gonzalez I, et al:
Partitioning of IGFBP-5 actions in myogenesis: IGF-independent
anti-apoptotic function. J Cell Sci. 117:1737–1746. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sokolović A, Sokolović M, Boers W,
Elferink RP and Bosma PJ: Insulin-like growth factor binding
protein 5 enhances survival of LX2 human hepatic stellate cells.
Fibrogenesis Tissue Repair. 3:32010.PubMed/NCBI
|
|
37
|
Fischer F, Schulte H, Mohan S, et al:
Associations of insulin-like growth factors, insulin-like growth
factor binding proteins and acid-labile subunit with coronary heart
disease. Clin Endocrinol (Oxf). 61:595–602. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim KS, Seu YB, Baek SH, et al: Induction
of cellular senescence by insulin-like growth factor binding
protein-5 through a p53-dependent mechanism. Mol Biol Cell.
18:4543–4552. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Godard MP, Whitman SA, Song YH and
Delafontaine P: Skeletal muscle molecular alterations precede
whole-muscle dysfunction in NYHA Class II heart failure patients.
Clin Interv Aging. 7:489–497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee DH, Kim JE and Kang YJ: Insulin like
growth factor binding protein-5 regulates excessive vascular smooth
muscle cell proliferation in spontaneously hypertensive rats via
ERK 1/2 phosphorylation. Korean J Physiol Pharmacol. 17:157–162.
2013. View Article : Google Scholar
|
|
41
|
Enari M, Sakahira H, Yokoyama H, et al: A
caspase-activated DNase that degrades DNA during apoptosis, and its
inhibitor ICAD. Nature. 391:43–50. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Thornberry NA and Lazebnik Y: Caspases:
enemies within. Science. 281:1312–1316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wolf BB, Schuler M, Echeverri F and Green
DR: Caspase-3 is the primary activator of apoptotic DNA
fragmentation via DNA fragmentation factor-45/inhibitor of
caspase-activated DNase inactivation. J Biol Chem. 274:30651–30656.
1999. View Article : Google Scholar : PubMed/NCBI
|
